Increasing evidence has indicated that IGF2BP3 is highly expressed and promotes tumor progression in NSCLC, [44] however, the molecular mechanism of IGF2BP3 in NSCLC has not been elucidated. Here, IGF2BP3 is linked to non-small cell lung carcinoma.